Treatment of Pelvic Venous Spur (May–Thurner Syndrome) with Self-Expanding Metallic Endoprostheses

• Published in: Cardiovascular and interventional radiology Vol. 21; no. 1; pp. 22 - 26
• Main Authors: Binkert, Christoph A., Schoch, Eric, Stuckmann, Gerd, Largiader, Jon, Wigger, Pius, Schoepke, Wolfdietrich, Zollikofer, Christoph L.
• Format: Journal Article
• Language: English
• Published: Heidelberg Springer 01.01.1998; Berlin
• Subjects: Adult; Biological and medical sciences; Blood Flow Velocity; Blood Vessel Prosthesis; Diseases of the cardiovascular system; Edema - diagnostic imaging; Edema - surgery; Female; Follow-Up Studies; Humans; Iliac Vein - diagnostic imaging; Iliac Vein - surgery; LEGS; Male; Medical sciences; Metals; Middle Aged; PATIENTS; Phlebography; RADIOLOGY AND NUCLEAR MEDICINE; Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects); Stents; SURGERY; SWELLING; Syndrome; Thrombectomy; THROMBOSIS; Thrombosis - diagnostic imaging; Thrombosis - surgery; VEINS; Human; Endoprosthesis; Treatment efficiency; Instrumentation therapy; Pelvic vein; Cardiovascular disease; Common iliac vein; Self developing; Long term; Obstruction; Stent; Vascular disease; Treatment; May-Thurner syndrome; Technique
• ISSN: 0174-1551; 1432-086X
• DOI: 10.1007/s002709900205

The application of self-expanding metallic endoprostheses (stents) to treat symptomatic pelvic venous spurs as an alternative to surgery. Wallstents with a diameter from 14 to 16 mm and one Cragg stent were placed in the left common iliac vein of eight patients (seven women, one man; mean age 42 years) with a symptomatic pelvic venous spur (left deep venous thrombosis or post-thrombotic leg swelling). Four patients had surgical thrombectomy prior to stent placement. Technical success with immediate reduction of left leg circumference was achieved in all eight patients. A primary patency rate of 100% was observed during an average follow-up of 3 years (range 10-121 months). There were no procedural or stent-related complications. The percutaneous transfemoral placement of self-expanding metallic stents is an effective minimally invasive alternative to surgery in the treatment of symptomatic pelvic venous spur.